ESTRO35 Programme Book

> External beam radiotherapy with HDR brachytherapy boost in prostate cancer: 5- and 8-year results R. Soumarova (Czech Republic), T. Blažek, L. Homola > HDR prostate brachytherapy: 3-D planned simultaneous integrated boost to the peripheral zone R. Hepp (Germany), L. Herberholz, A. Petry, T. Eggert, L. Piotrowski, C. Morgenstern, G. Schabl, R. Galalae > Ten year patient reported quality of life following I-125 prostate brachytherapy monotherapy A. Henry (UK), B. Sethugavalar, T. Witteveen, B. Al-Qaisieh, P. Bownes, J. Smith, B. Carey, K. Franks, D. Mitchell, D. Bottomley > Image-guided impact on the brachytherapy prostate treatment quality V. Cerboneschi (Italy), V. Ravaglia, M. Paoluzzi, M. Mignogna, M. Mignogna > LTB control and toxicity for favorable and intmed Risk pts using real time IO-PSI prostate BT alone A. Raben (USA), A. Sarkar, A. Hanlon, H.C. Chen, F. Mourtada, A. Glick, M. Lobis, S. Terranova, T. Desperito, D. Cozzolino > Inhibition of STAT3 enhances the radiosensitising effect of Temozolomide in Glioblastoma model I.A. Kim (Republic of Korea), T. Han, B. Cho, E. Choi, S. Song, S. Paek > Activation of immune cells and enhanced efficacy of radiotherapy by anti-TIP1 antibodies in cancer D. Hallahan (USA), V. Kapoor, D. Thotala, H. Yan > Therapeutic potential of the YB-1/Notch-3 interaction in prostate cancer N. McDermott, A. Meunier, C. Haynes, A. Flores, A. O’Callaghan, L. Marignol (Ireland) > Nanoparticle mediated tumor vascular disruption: a novel strategy in radiation therapy S. Kunjachan (USA), A. Detappe, R. Kumar, S. Sridhar, G.M. Makrigiorgos, R. Berbeco

POSTERS

PO-0975

PO-0976

PO-0977

PO-0978

PO-0979

Poster RADIOBIOLOGY TRACK: MOLECULAR TARGETED AGENTS AND RADIOTHERAPY

PO-0980

PO-0981

PO-0982

PO-0983

INTERDISCIPLINARY RADIOBIOLOGY

CLINICAL BRACHYTHERAPY PHYSICS

RTT

YOUNG

POSTERS AND ELECTRONIC POSTERS | PROGRAMME AND EXHIBITION GUIDE

204